Home/Filings/4/A/0001607062-21-000059
4/A//SEC Filing

PETKANAS DEAN 4/A

Accession 0001607062-21-000059

CIK 0001615999other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 7:08 PM ET

Size

8.9 KB

Accession

0001607062-21-000059

Insider Transaction Report

Form 4/AAmended
Period: 2021-03-12
PETKANAS DEAN
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2021-03-12$0.13/sh+692,308$90,00022,984,029 total(indirect: See Note)
  • Award

    Employee Stock Option (Right to Buy)

    2021-03-12+1,450,0001,450,000 total
    Exercise: $0.13Exp: 2031-03-11Common Stock (1,450,000 underlying)
Footnotes (4)
  • [F1]The reporting person agreed to accept 692,308 restricted shares of the issuer's common stock in exchange for the discharge of an aggregate of $90,000 of accrued but unpaid monies payable by the issuer to the reporting person as a portion of his salary. The issuance was approved by the issuer's board of directors on March 12, 2021. The price of the shares acquired by the reporting person is equal to the closing price of the Company's common stock on March 11, 2021, which was $0.13 per share.
  • [F2]This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on March 16, 2021 (the "Original Form 4") is being filed to remove the second transaction reported in Table I of the Original Form 4, reporting the acquisition of 192,308 shares of the Issuer's common stock, which transaction was included in error and did not occur. This Form 4/A amends and restates in its entirety the Original Form 4, including only those transactions that occurred on March 12, 2021.
  • [F3]Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
  • [F4]1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter.

Issuer

NEUROPATHIX, INC.

CIK 0001615999

Entity typeother

Related Parties

1
  • filerCIK 0000944235

Filing Metadata

Form type
4/A
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:08 PM ET
Size
8.9 KB